Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs
about
Angioedema: Classification, management and emerging therapies for the perioperative physicianHistological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticariaA review of recent journal highlightsLeukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean populationFamilial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variantTolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literatureAngioedema associated with aspirin and rofecoxibEtoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugsManagement options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivitySafety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramideClassification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugsA disease marker for aspirin-induced chronic urticaria.Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.Urticaria and angioedema. Controlling acute episodes, coping with chronic cases.Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.Association of specific IgE to staphylococcal superantigens with the phenotype of chronic urticaria.Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.Nonallergic drug hypersensitivity reactions.Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review.Hypersensitivities to non-steroidal anti-inflammatory drugs.Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologist.Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria.Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity.An update on acute and chronic urticaria for the primary care provider.Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs.Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria.
P2860
Q28076493-1B0A62B2-B604-4917-BB19-B6A2240EC94AQ28167614-8B8687C6-4896-4C92-8E67-C308EBF2814CQ28168449-EB2CD206-131B-4AED-8A74-76C4B921CE6CQ28193999-B43C4D74-C219-45EE-879E-CAAB39B3CA4EQ28194635-E218F906-A567-444F-A15D-C73496C7B79FQ28210177-C4BA3AE2-995D-4DF4-B372-24AE76F9E394Q28212096-35F2D128-8970-4008-A263-5B410F049771Q28217821-8CD1B993-8CE3-4B21-AB81-C89EE52D0DF3Q28217965-823A49F3-F0D8-4BE4-949E-83E30FBF95F0Q28218881-D37AABED-AF38-4EB3-B337-1F83081CFDDFQ28300126-284DEC00-248B-4256-BE15-75D1B3502964Q34072462-E4BEF861-7077-4DDB-A880-63ADAAA64B01Q34188879-25E9F814-F8EE-47ED-A04D-DA48A006939EQ36158280-DD314BDC-8668-4ABB-A047-70A9641DDA60Q36834393-CA913CA4-1377-47A8-9C68-8CAB9483FEB7Q36966114-90A46676-DB47-4043-8F82-D45F3DE792E9Q37605444-734D5FB2-0640-4902-A792-88B3CD001DC7Q38029476-1CB9BAAA-F90C-4544-8FBA-F35781BB52ECQ38047191-0A05EB8F-E621-487A-8095-B1B5C010BD16Q38236684-DA232C28-C4DB-4ADF-A97C-81E0CD8A487AQ39573055-8981F162-2B99-433C-8F74-E64B0B7D10ECQ39633087-7A0B4201-019E-418C-A955-1CCF53A93831Q39751791-3A6448A8-733E-408B-A2BC-A9B333807F91Q46140535-01BB5110-12AF-4B15-B012-418F50996D15Q46493810-F7C3101F-5685-4BB9-A10C-FF32862FF28BQ46643325-1B3DEFAD-E206-4AE9-99DD-91E767DAF00B
P2860
Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@ast
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@en
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@nl
type
label
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@ast
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@en
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@nl
prefLabel
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@ast
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@en
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@nl
P2093
P3181
P1433
P1476
Safety of cyclooxygenase 2 inh ...... roidal anti-inflammatory drugs
@en
P2093
Artur Zembowicz
Lucyna Mastalerz
Malgorzata Setkowicz
Waldemar Radziszewski
P304
P3181
P356
10.1001/ARCHDERM.139.12.1577
P407
P577
2003-12-01T00:00:00Z